Alkeon Capital Management LLC Catalent, Inc. Transaction History

Alkeon Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $17 Million - $26.6 Million	-234,987 Reduced 30.47%	536,216 $38.8 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $11.9 Million - $15.6 Million	136,858 Added 21.57%	771,203 $82.7 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $31.5 Million - $41.6 Million	334,345 Added 111.45%	634,345 $70.3 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $35.9 Million - $41.7 Million	300,000 New	300,000 $38.4 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.